Xencor (XNCR) Appoints Bart Cornelissen as Chief Financial Officer
            
                
                    Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen [alumnus RSM…
                
            
            
                
                    
                        Outlet: 
                        StreetInsider.com
                    
                    
                        Media Type:
                        Online
                    
                
            
            
                
                    Tuesday, 9 April 2024